Director, US GI Market Research

The Opportunity

Reporting to the Senior Director, US GI Analytics & Insights, the Director, US GI Market Research will serve as the US Market Research lead for Revolution Medicines' GI cancer portfolio. This role will partner closely with US Commercial, US Market Access, Global Market Research, Medical Affairs, Clinical Development, and Business Operations to generate actionable insights that inform portfolio strategy, launch readiness, commercialization planning, and business performance. The role requires a strong understanding of the PDAC and CRC cancer treatment landscape, patient journey, biomarker-driven markets, and oncology data assets.

Responsibilities

• Leads, designs, and executes US primary market research projects with HCPs, patients, and payors.
• Initiates and facilitates activities that enhance partners' knowledge regarding the relevant US market and potential product attitudes, usage, market dynamics, and competition (e.g., treatment flows, target product profiles, opportunity assessments, market landscape research).
• Shares the voice of the US community (physicians, patients, payors) by maintaining and communicating a holistic understanding of the marketplace synthesized from primary and secondary sources.
• Reinforces market research best practices; identifies market research and data sources, vendor options, and methodologies best suited to address a business need.
• Manages third parties associated with this function.
• Communicates and aligns key internal stakeholders around market research objectives and outputs, qualifying results based on strength of data and identifying limitations.
• Develops and presents timely final reports and actionable recommendations to key stakeholders and senior leadership.
• Communicates insights and strategic implications to senior leadership through clear, concise, and compelling recommendations.
• Shapes situation analysis as part of launch planning to provide a comprehensive understanding of the market.
• Partners with cross-functional teams like marketing, sales, access, and medical to provide a clear view of the market.
• Demonstrates ability to quickly understand complex markets, disease states, competitive landscapes, and relevant market and managed care dynamics.
• Exhibits analytical rigor in valuation of business opportunities and quantification of risk.
• Partners with US Forecasting, US Data Analytics, and Competitive Intelligence colleagues to develop an integrated view of market performance and future growth opportunities.
• Travels as needed.

Required Skills, Experience and Education

• Bachelor's degree required (advanced degree preferred) with 10+ years of progressive experience in a pharmaceutical, biotechnology, or strategic consulting role with 6+ years of experience in a strategic analytics role.
• Oncology market research experience required; GI cancer (PDAC and/or CRC) experience strongly preferred.
• Experience in market development and new product launches.
• Extensive primary research and secondary analytical skills required; ability to translate data and learning into actionable recommendations for business growth.
• Track record of being a collaborative team player, adaptive to meet the needs of a growing business.
• Strong problem solver with experience leveraging a variety of research and analytical vendors, study designs, and building quality research vendor partnerships.
• Demonstrated ability to influence senior management and key business partners.
• Proven experience in a smaller, rapidly growing company.
• Excellent organizational skills and ability to prioritize effectively to deliver results within reasonably established timelines.
• Ability to represent Revolution Medicines well with internal and external stakeholders, including strong interpersonal skills including verbal and written communication.
• Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients.

Preferred Skills

• MBA, MPH, MS, or PhD.
• Deep understanding of PDAC and/or CRC and biomarker-driven oncology markets.
• Experience supporting targeted oncology therapies.
• Prior experience in a growth-stage biotechnology company.